Rabi Tawil MD

#

Professor of Neurology


University of Rochester

Dr. Tawil is co-director of the MDA Neuromuscular Disease Clinic at the University of Rochester. He is also Director of the Neuromuscular Pathology Laboratory and is responsible for the interpretation of all muscle biopsy samples use for diagnosing muscle diseases. His clinical interests include all acquired and inherited muscle diseases, myasthenia gravis and amyotrophic lateral sclerosis. He has special expertise in facioscapulohumeral muscular dystrophy (FSHD), the non-dystrophic myotonias and the periodic paralyses.

See also: https://www.urmc.rochester.edu/people/21155383-rabi-n-tawil

Grants Awarded
Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)
Jul 10, 2020
Research - Clinical
The primary goal of this proposal is to hasten therapeutic development for FSHD and improve care delivery by creating a standard clinic-based protocol informed by best practice guidelines to determine the predictive value of clinical characteristics and motor assessments on motor and health outcomes.
CTRN International Sites
Jan 18, 2018
Research - Clinical
Adding two clinical sites to a U01 grant for the Clinical Trial Research Network.
Identification of Serum Biomarkers for Measurement of FSHD Progression
Jun 1, 2014
Research - Clinical
This study aims to identify markers in human serum that correlate with FSH pathology.
Optimizing the Utility of the National Registry for FSHD Research and Trial Recruitment
May 16, 2016
Research - Clinical
Offer present and future National FSHD Registry participants who have not been genetically confirmed, the chance to get detailed genetic testing for both FSHD1 and FSHD2.